Bioject Medical Technologies Inc.
7620 SW Bridgeport Road
Portland
Oregon
97224
United States
Tel: 503-639-7221
109 articles about Bioject Medical Technologies Inc.
-
Bioject Medical Technologies Inc. Announces The Appointment Of A Distributor For China
5/12/2014
-
Bioject Medical Technologies Inc. Adds To Its Global Distribution Network
4/22/2014
-
Bioject Medical Technologies Inc. Seeking To Restructure Its Balance Sheet
3/21/2014
-
Bioject Medical Technologies Inc. Enters Into Distribution Agreement With FlashMed Inc. In Ecuador
10/30/2013
-
Bioject Medical Technologies Inc. Enters Into Agreement With Fondaco PTE LTD for Distribution of Full Line of Needle Free Injection Devices in Asia
10/23/2013
-
Bioject Medical Technologies Inc. Enters Into Three Distribution Agreements
3/21/2013
-
Bioject Medical Technologies Inc. Reports Unaudited Year-End and Quarterly 2012 Financial Results
2/12/2013
-
Bioject Medical Technologies Inc. Reports Unaudited Year-End 2011 and First Quarter 2012 Financial Results
7/23/2012
-
Bioject Medical Technologies Inc. Retains Financial Advisor to Explore Strategic Alternatives
1/18/2012
-
Bioject Medical Technologies Inc. Retains Financial Advisor to Explore Strategic Alternatives
1/18/2012
-
Bioject Medical Technologies Inc. Announces Change in President and Chief Executive Officer
11/11/2011
-
Bioject Medical Technologies Inc. Reports Third Quarter 2011 Financial Results
11/9/2011
-
Bioject Medical Technologies Inc. on Use of Jet Injectors with Influenza Vaccines
10/24/2011
-
Fred Meyer to Offer Bioject Medical Technologies Inc. Needle-Free Flu Vaccines for First Time
9/8/2011
-
Bioject Medical Technologies Inc. Reports Second Quarter 2011 Financial Results
8/11/2011
-
Bioject Medical Technologies Inc. to Report Second Quarter 2011 Financial Results
8/4/2011
-
Bioject Medical Technologies Inc. Reports Third Quarter 2010 Financial Results
11/11/2010
-
Bioject Medical Technologies Inc. to Report Third Quarter 2010 Financial Results
11/4/2010
-
Bioject Medical Technologies Inc. Release: Biojector(R)2000 Utilized in a Human Clinical Trial of DNA-MVA HIV Vaccine
9/28/2010
-
Bioject Medical Technologies Inc. Reports Second Quarter 2010 Financial Results
8/5/2010